These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5645989)

  • 1. Comparison of norepinephrine and isoproterenol in experimental coronary shock. Observations on the effects of dextran infusion.
    Fearon RE
    Am Heart J; 1968 May; 75(5):634-48. PubMed ID: 5645989
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of isoproterenol,l-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction.
    Mueller H; Ayres SM; Giannelli S; Conklin EF; Mazzara JT; Grace WJ
    Circulation; 1972 Feb; 45(2):335-51. PubMed ID: 5009478
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of vasoactive drugs on oxygen consumption in endotoxin shock.
    Anas P; Hardy JD
    Arch Surg; 1969 Feb; 98(2):189-93. PubMed ID: 4885452
    [No Abstract]   [Full Text] [Related]  

  • 4. The physiologic basis for treatment of shock associated with myocardial infarction.
    Gunnar RM; Pietras RJ; Stavrakos C; Loeb HS; Tobin JR
    Med Clin North Am; 1967 Jan; 51(1):69-81. PubMed ID: 4869243
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamics, coronary blood flow, and myocardial metabolism in coronary shock; response of 1-norepinephrine and isoproterenol.
    Mueller H; Ayres SM; Gregory JJ; Giannelli S; Grace WJ
    J Clin Invest; 1970 Oct; 49(10):1885-902. PubMed ID: 5460498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of adrenergic stimulating and blocking agents in cardiogenic shock and low output state after myocardial infarction.
    Misra SN; Kezdi P
    Am J Cardiol; 1973 Jun; 31(6):724-35. PubMed ID: 4145230
    [No Abstract]   [Full Text] [Related]  

  • 7. Modification of experimental myocardial infarct size by cardiac drugs.
    Puri PS
    Am J Cardiol; 1974 Apr; 33(4):521-8. PubMed ID: 4818050
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of isoproterenol on hemodynamic alterations, myocardial metabolism, and coronary flow in experimental acute myocardial infarction with shock.
    Kuhn LA; Kline HJ; Goodman P; Johnson CD; Marano AJ
    Am Heart J; 1969 Jun; 77(6):772-83. PubMed ID: 5770150
    [No Abstract]   [Full Text] [Related]  

  • 9. Isoproterenol and norepinephrine therapy for pulmonary embolism shock.
    Rosenberg JC; Hussain R; Lenaghan R
    J Thorac Cardiovasc Surg; 1971 Jul; 62(1):144-50. PubMed ID: 5091678
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute myocardial infarction in man. Comparative hemodynamic effects of norepinephrine and glucagon.
    Diamond G; Forrester J; Danzig R; Parmley WW; Swan HJ
    Am J Cardiol; 1971 Jun; 27(6):612-6. PubMed ID: 5092474
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of lipolytic and inotropic stimulation on myocardial ischemic injury.
    Kjekshus JK
    Acta Med Scand Suppl; 1976; 587():35-42. PubMed ID: 1062131
    [No Abstract]   [Full Text] [Related]  

  • 12. Left ventricular contraction and the therapy of cardiogenic shock.
    Ross J
    Circulation; 1967 Apr; 35(4):611-3. PubMed ID: 6024005
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of isoproterenol and norepinephrine on myocardial function in experimental cardiogenic shock.
    Cronin RF
    Am Heart J; 1967 Sep; 74(3):387-95. PubMed ID: 6041067
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic effects of isoproterenol and noradrenalin in experimental shock.
    Dedichen H; Schenk WG
    Acta Chir Scand; 1973; 139(3):213-8. PubMed ID: 4698482
    [No Abstract]   [Full Text] [Related]  

  • 15. The catecholamines: reappraisal of their use for acute myocardial infarction and the low cardiac output syndromes.
    Kones RJ
    Crit Care Med; 1973; 1(4):203-20. PubMed ID: 4357984
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental myocardial infarction. X. Efficacy of glucagon in acute and healing phase in intact conscious dogs: effects on hemodynamics and myocardial oxygen consumption.
    Kumar R; Molokhia FA; Norman JC; Inamdar AN; Messer JV; Abelmann WH; Hood WB; Sharma GV
    Circulation; 1972 Jan; 45(1):55-64. PubMed ID: 5007038
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of shock in acute myocardial infarction.
    Pema PJ
    J Am Osteopath Assoc; 1971 Mar; 70(7):692-702. PubMed ID: 4926966
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac performance and metabolism in shock due to acute myocardial infarction in man: response to catecholomines and mechanical cardiac assist.
    Mueller H; Ayres SM; Giannelli S; Conklin EF; Mazzara JT; Grace WJ
    Trans N Y Acad Sci; 1972 Apr; 34(4):309-33. PubMed ID: 4502562
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of norepinephrine and phenylephrine on myocardial energetics.
    Krasnow N
    Am Heart J; 1968 Nov; 76(5):660-73. PubMed ID: 4880636
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of isoproterenol and 1-norepinephrine on function, coronary flow, and oxygen consumption of the intact left ventricle.
    Abe T; Malik AB; O'Kane HO; Geha AS
    Surgery; 1973 Oct; 74(4):562-9. PubMed ID: 4729221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.